Balasubramanian Deepika | Nanotechnology | Best Paper Award

Posted on by Best Paper Awards

Dr. Balasubramanian Deepika | Nanotechnology | Best Paper Award

Senior Lecturer at Saveetha Medical Collage and Research Institution, India

Author's Profile

Orcid
Google Scholar

Summary

Dr. Deepika B is an accomplished researcher in the field of Medical Biotechnology, specializing in cancer biology, nanotechnology, and translational medicine. With a strong foundation in molecular techniques, in vivo experimentation, and innovative therapeutic approaches, she brings over three years of rich research experience. Her work is distinguished by its interdisciplinary nature, combining nanomedicine with oncology to develop novel therapeutic solutions.

Educational Details

Dr. Deepika earned her Ph.D. in Medical Biotechnology (2021–2024) from Chettinad Academy of Research and Education, Tamil Nadu, India. Her doctoral research focused on evaluating the anticancer efficacy of nano-nutraceuticals. She also holds an M.Sc. in Medical Biotechnology (2018–2020) from the same institution, with a thesis on nano-kaempferol and its angiogenesis-inhibitory properties. She completed her B.Sc. in Biotechnology (2016–2018) from Valliammal College for Women, affiliated with the University of Madras. Additionally, she completed certified training in Animal Handling and Experimentation from TANUVAS and undertook an internship in Clinical Research at Deepam Hospitals, Chennai.

Professional Experience

Throughout her academic and research career, Dr. Deepika has worked extensively in cell culture, molecular biology, and animal models, including zebrafish embryos and Swiss albino mice. She has performed a wide range of experimental procedures such as DNA/RNA extraction, PCR, tumor induction, cytotoxicity assays, and drug efficacy analysis. Her expertise also includes photochemical characterization and nanomaterial synthesis. She has collaborated on numerous interdisciplinary projects and demonstrated leadership in mentoring and research management.

Research Interests

Her research is focused on cancer biology, nanotechnology-based drug delivery, wound healing, and biocompatibility studies. Dr. Deepika explores natural bioactive compounds and their nanoformulations for cancer therapy and has contributed to studies involving toxicity profiles, gene expression analysis, and therapeutic applications of nanomaterials in biomedical science.

Author Metrics

Dr. Deepika has authored 24 research publications in Scopus-indexed journals with a cumulative impact factor of 50.59, including several Q1-ranked journals. Her current h-index is 10 with over 210 citations. She is also listed in ORCID: https://orcid.org/0000-0003-4441-7863, highlighting her contributions to high-impact biomedical research.

Awards and Honors

Dr. Deepika holds two granted Indian patents: one on the nanoformulation of Passiflora incarnata leaf extract (Patent No. 437722) and another on titanium dioxide nanoparticles synthesized from potato peel extract (Patent No. 453713). Additionally, she received a copyright registration for her COVID-19 side-effects survey study. Her scientific excellence and contribution to biotechnology have earned her recognition in the academic community.

Publication Top Notes

1. Multiple Radiations and its Effect on Biological Systems – A Review on In Vitro and In Vivo Mechanisms

Authors: D. Balasubramanian, G. Agraharam, A. Girigoswami, K. Girigoswami
Journal: Annals of Medicine, 57(1), Article ID: 2486595
Year: 2025
Highlights: This comprehensive review outlines the biological impacts of multiple radiation exposures, focusing on cellular and systemic responses observed in both in vitro and in vivo models. It discusses oxidative stress, DNA damage, apoptosis, and radioprotective strategies.

2. Dual Mechanism of Amphiroa anceps: Antiangiogenic and Anticancer Effects in Skin Cancer

Authors: G. Janani, A. Girigoswami, B. Deepika, S. Udayakumar, D.J. Mercy, et al.
Journal: Chemistry & Biodiversity
DOI: e202500626
Year: 2025
Highlights: This study demonstrates that Amphiroa anceps exhibits dual functionality by inhibiting angiogenesis and exerting cytotoxic effects on skin cancer cells, offering potential for novel marine-derived anticancer therapies.

3. Inhibitory Effect of Nano-Formulated Extract of Passiflora incarnata on Dalton’s Lymphoma Ascites-Bearing Swiss Albino Mice

Authors: B. Deepika, G. Janani, D. Jessy Mercy, S. Udayakumar, A. Girigoswami, K. Girigoswami
Journal: Pharmaceutics, 17(2), Article 270
Year: 2025
Highlights: This in vivo study confirms the anticancer potential of nano-formulated Passiflora incarnata extract by significantly suppressing tumor growth in DLA-bearing mice, with improved safety and efficacy compared to traditional formulations.
Impact Factor: 4.9 | Q1 Journal

4. Preparation of Titanium Dioxide Nanoparticles from Solanum Tuberosum Peel Extract and its Applications

Authors: A. Girigoswami, B. Deepika, A.K. Pandurangan, K. Girigoswami
Journal: Artificial Cells, Nanomedicine, and Biotechnology, 52(1), pp. 59–68
Year: 2024
Highlights: A green synthesis approach is used to develop titanium dioxide nanoparticles from potato peel extracts, showcasing effective antibacterial, antioxidant, and photocatalytic properties.
Impact Factor: 5.8 | Q1 Journal

5. Peony-Shaped Zinc Oxide Nanoflower Synthesized via Hydrothermal Route Exhibits Promising Anticancer and Anti-Amyloid Activity

Authors: A. Girigoswami, B. Deepika, S. Udayakumar, G. Janani, D.J. Mercy, K. Girigoswami
Journal: BMC Pharmacology and Toxicology, 25(1), Article 101
Year: 2024
Highlights: This work introduces a novel zinc oxide nanoflower morphology synthesized via a hydrothermal method, exhibiting high efficiency in inhibiting both cancer cell proliferation and amyloid aggregation.
Impact Factor: Q2 Journal

Conclusion

Dr. Balasubramanian Deepika presents a strong and competitive case for the Best Paper Award. Her cutting-edge contributions to nanomedicine and cancer biology, combined with solid publication metrics and patents, showcase her as a young scientist with the potential to drive significant future advancements. Minor improvements in international visibility and translational depth could place her research on a global innovation map.

Fatma Rahmouni | Biology | Best Paper Award

Posted on by Best Paper Awards

Dr. Fatma Rahmouni | Biology | Best Paper Award

Assistant at Faculty of Medicine of sfax, Tunisia

Author Profile

Scopus

Summary

Dr. Rahmouni Fatma is a Tunisian biological scientist and academic with a strong focus on toxicology, pharmacology, and the therapeutic potential of medicinal plants. Her research integrates in vivo, in vitro, and in silico approaches to evaluate the biological impact of natural products, particularly in protecting organs from damage caused by oxidative stress and environmental toxicants. With over a decade of experience in academic and research roles, she has established herself as a recognized contributor in the field of experimental biology, specifically in the application of Teucrium polium for hepatoprotection and anticancer activity.

Educational Background

Dr. Fatma holds a PhD in Biological Sciences from the Faculty of Medicine, University of Sfax, Tunisia, awarded in 2018–2019. Her doctoral thesis was titled “Evaluation of the protective effects of Teucrium polium on the lesional aspects of CCl₄ in rats and anti-tumor effects on malignant HeLa cells,” reflecting her deep engagement with experimental toxicology and cancer biology. She previously completed a Master’s degree in Biodiversity and Aquatic Resources at the same university in 2011–2012 and earned her Licence degree in 2009–2010. Her academic journey began with a high school diploma from Secondary School Mezzouna, Sidi Bouzid, in 2005–2006.

Professional Experience

Dr. Rahmouni has held several academic and research roles across multiple faculties in Tunisia. She currently serves as a Contractual Assistant at the Faculty of Sciences of Gabes (2024–2025). Prior to this, she held consecutive researcher contracts at the Faculty of Sciences and Faculty of Medicine, University of Sfax, between 2019 and 2023. From 2015 to 2017, she also worked as an educational trainer for practical courses in histology and biochemistry. Her earlier teaching experience includes a teaching contract in 2015–2016 at the Faculty of Medicine, Sfax, where she mentored students in laboratory skills and applied biology.

Research Interests

Her primary research interests lie in evaluating the pharmacological and toxicological properties of natural compounds, especially Teucrium polium, for their protective roles against oxidative stress, liver and kidney damage, genotoxicity, and fertility impairment. She is equally interested in reproductive toxicology, histological analysis, environmental pollutants, and the biochemical mechanisms underlying tissue damage and recovery. She also explores cancer biology by studying the antiproliferative effects of plant extracts on HeLa and other cancer cell lines.

Author Metrics

Dr. Rahmouni has authored or co-authored over 19 scientific publications, many in high-impact peer-reviewed journals such as Toxicology Mechanisms and Methods, Life, BioFactors, Andrologia, and Frontiers in Physiology. As a first author, she has published studies with impact factors ranging between 2.1 and 6.1. Her collaborative research spans multiple disciplines, including molecular biology, environmental sciences, and pharmacognosy. Her growing citation record reflects her consistent contributions to biomedical science and experimental toxicology. (Note: Google Scholar, ORCID, or Scopus IDs can be added upon availability.)

Awards and Honors

Dr. Fatma has been an active participant and speaker in both national and international conferences, presenting her research through more than 18 oral and poster communications. She has been recognized for her work at events such as the International Symposium on Medicinal Plants and the Tunisian Society of Biological Sciences Congress. Her research was also featured prominently in toxicology and physiology forums. She has co-supervised Master’s-level research projects and continues to play an essential role in academic training, mentoring, and scientific dissemination.

Publication Top Notes

1. Neuroprotective and Antioxidant Effects of Urtica dioica Extract Against Chlorpyrifos-Induced Toxicity: An In Vivo Study

Journal: 3 Biotech
Year: 2025
Authors: (Names not displayed, assumed Dr. Rahmouni Fatma is one of the co-authors)
Summary:
This study investigates the protective effects of Urtica dioica (stinging nettle) extract in counteracting chlorpyrifos-induced neurotoxicity using a rodent model. The research assesses oxidative stress biomarkers, histopathological alterations in brain tissue, and behavioral changes, demonstrating significant neuroprotective and antioxidant activity of the extract. The findings support Urtica dioica as a promising natural remedy against pesticide-induced neurotoxicity.

2. Phytochemical Composition of Urtica dioica Essential Oil with Antioxidant and Anti-inflammatory Properties: In Vitro and In Vivo Studies

Journal: Current Pharmaceutical Biotechnology
Year: 2025
Authors: (Includes Dr. Rahmouni Fatma and others)
Citations: 4
Summary:
This article focuses on the phytochemical profiling of Urtica dioica essential oil, highlighting key active constituents through GC-MS analysis. Both in vitro (cell-based assays) and in vivo (animal models) experiments revealed notable antioxidant and anti-inflammatory effects, suggesting therapeutic applications of the essential oil in managing oxidative and inflammatory diseases. The study strengthens the pharmacological basis for Urtica dioica in traditional and modern medicine.

Conclusion

Dr. Rahmouni Fatma is an excellent candidate for the Best Paper Award in her domain. Her body of work reflects scientific rigor, innovation, and relevance to global health challenges. Her dual strength in phytochemical research and experimental toxicology places her among researchers making tangible contributions to biomedical science. Recognizing her with a Best Paper Award would be both well-deserved and motivational, encouraging further research in plant-based therapeutics and toxicological safety.